Adage Capital Partners
IPSC icon

Adage Capital Partners’s Century Therapeutics IPSC Stock Holding History

Adage Capital Partners’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.56M Buy
3,789,538
+1,950,838
+106% +$4.1M 0.01% 723
2025
Q4 		$1.83M Buy
+1,838,700
New +$1.12M ﹤0.01% 844
2024
Q4 		– Sell
-1,322,751
Closed -$2.26M – 920
2024
Q3 		$2.26M Hold
1,322,751
– – ﹤0.01% 778
2024
Q2 		$3.37M Buy
+1,322,751
New +$4.18M 0.01% 747

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Adage Capital Partners's IPSC Position: Q1 2026 in Review

Adage Capital Partners increased its Century Therapeutics (IPSC) stake by 106% in Q1 2026, buying an estimated $4.1M and bringing the position to 3,789,538 shares worth $8.56M. The position accounts for 0.01% of the portfolio, ranked #723.

Adage Capital Partners first reported a position in IPSC in Q2 2024 and has held it in 4 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Adage Capital Partners held 3,789,538 shares of Century Therapeutics worth $8.56M as of Q1 2026.
  • Adage Capital Partners bought 1,950,838 Century Therapeutics shares in Q1 2026, an estimated $4.1M.
  • Century Therapeutics made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #723 holding.
  • Adage Capital Partners first reported a position in Century Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.